Showing results (31-40 of 10,058) with videos related to
Sort By:
Pageof 1,006
Current Pharmaceutical Design|June 2, 2010
What can actigraphy add to the concept of labschool design in clinical trials?Henrik Uebel, Björn Albrecht, Roumen Kirov, et al.Current Pharmaceutical Design|July 13, 2010
Nanoparticulate formulations for paclitaxel delivery across MDCK cell monolayerJingwei Xie, Chenlu Lei, Yong Hu, et al.Current Pharmaceutical Design|July 13, 2010
Effect of particle formulation on dry powder inhalation efficiencyMeer Saiful Hassan, Raymond LauCurrent Pharmaceutical Design|July 21, 2010
Ligand-based computer-aided discovery of tyrosinase inhibitors. Applications of the TOMOCOMD-CARDD method to the elucidation of new compoundsYovani Marrero-Ponce, Gerardo M Casañola-Martín, Mahmud Tareq Hassan Khan, et al.Current Pharmaceutical Design|July 21, 2010
Predicting drugs and proteins in parasite infections with topological indices of complex networks: theoretical backgrounds, applications, and legal issuesHumberto González-Díaz, Fernanda Romaris, Aliuska Duardo-Sanchez, et al.Current Pharmaceutical Design|July 21, 2010
Ontologies of drug discovery and design for neurology, cardiology and oncologyJosé M Vázquez-Naya, Marcos Martínez-Romero, Ana B Porto-Pazos, et al.Current Pharmaceutical Design|July 21, 2010
Review of QSAR models for enzyme classes of drug targets: Theoretical background and applications in parasites, hosts, and other organismsRiccardo Concu, Gianni Podda, Florencio M Ubeira, et al.Current Pharmaceutical Design|August 12, 2010
Structural determinants of the multifunctional profile of dual binding site acetylcholinesterase inhibitors as anti-Alzheimer agentsCarles Galdeano, Elisabet Viayna, Pau Arroyo, et al.Current Pharmaceutical Design|August 21, 2010
Targeted therapy options for treatment of bone metastases; beyond bisphosphonatesJ T Buijs, C C H J Kuijpers, G van der PluijmCurrent Pharmaceutical Design|May 21, 2010
Aptamer-based carbohydrate recognitionWei Sun, Lupei Du, Minyong LiPageof 1,006